Ultragenyx Pharmaceutical | RARE - الربح الإجمالي على المبيعات





الربح الإجمالي على المبيعات تغيير تاريخ
Acadia Pharmaceuticals USD 279.64M 36.37M 2026-06
Agios Pharmaceuticals USD 19.43M 1.34M 2026-03
Alnylam Pharmaceuticals USD 992.69M 167.68M 2026-06
BioCryst Pharmaceuticals USD 214.41M 61.36M 2026-06
BioMarin Pharmaceutical USD 713.42M 142.21M 2026-06
Immunic 0 0 2025-03
Insmed USD 356.19M 99.73M 2026-06
Ionis Pharmaceuticals USD 265M 22M 2026-06
Karyopharm Therapeutics USD 33.72M 1.13M 2026-03
Kyowa Hakko Kirin JPY 109.03B 20.79B 2026-06
MacroGenics USD 11.24M 19.87M 2026-03
Moderna USD -566M 792M 2026-03
Neurocrine Biosciences USD 800.7M 12.8M 2026-03
PTC Therapeutics USD 232.94M 84.56M 2026-03
Puma Biotechnology USD 20.32M 24.85M 2024-09
Regeneron Pharmaceuticals USD 3.71B 778.2M 2026-06
Sarepta Therapeutics USD 251.15M 370.2M 2026-06
Ultragenyx Pharmaceutical USD 180M 74M 2026-06
Vertex Pharmaceuticals USD 2.84B 242.4M 2026-06